Navigation Links
International team cracks mammalian gene control code
Date:4/20/2009

An international consortium of scientists, including researchers from The University of Queensland (UQ), have probed further into the human genome than ever before.

They have discovered how genes are controlled in mammals, as well as the tiniest genetic element ever found.

Their discoveries will be published in three milestone papers in leading journal Nature Genetics.

The research was coordinated by the RIKEN Yokohama Omics Science Center in Japan as part of the FANTOM4 consortium, with researchers from UQ's Institute for Molecular Bioscience playing major roles in two of the papers.

PhD student Ryan Taft led one paper, on which Professor John Mattick was the senior author, while Associate Professor Sean Grimmond was a senior author on another paper led by Dr Geoff Faulkner.

"FANTOM4 has shown that instead of having one or a few 'master regulator' genes that control growth and development, there is a sophisticated network of regulatory elements that subtly influence the ways in which genes are expressed in different cells in the body," Professor John Mattick said.

This information will be very useful to medical and biological researchers, according to Associate Professor Sean Grimmond.

"We can use it to discover how cells transform from rapidly-growing 'blank slate' cells to mature cells with a specific function. This knowledge will help us determine, for example, why some cells turn cancerous, or how to control stem cells for use in regenerative medicine."

One of the papers describes the discovery of tiny RNAs, the smallest genetic elements yet known, which are linked to the expression of individual genes. Tiny RNAs are 18 nucleotides long, 100 times smaller than an average gene.

"Researchers had previously noticed small lengths of RNA in the genome, but thought that they were degraded segments of larger genetic elements," Mr Taft said.

"We found that th
'/>"/>

Contact: Bronwyn Adams
b.adams@imb.uq.edu.au
61-733-462-134
Research Australia
Source:Eurekalert

Page: 1 2

Related medicine news :

1. V. Craig Jordan, Internationally Renowned Breast Cancer Scientist, Joins Georgetowns Lombardi Comprehensive Cancer Center
2. MMR Information Systems, Inc. Announces 250,000 Membership Milestone and Granting of International Patents
3. PRA International to Present Key Challenges for Safety Professionals at the World Drug Safety Congress: PRA Experts discussing REMS at Washington DC Conference
4. VirtualScopics Scientists to Present at International Society for Magnetic Resonance in Medicine 17th Scientific Meeting and Exhibition
5. Medical International Technology Inc. "MIT" announces a minimum of 6 million dollars exclusive agreement for a period of 5 years with a Malaysian Distributor for its Med-Jet(R) Needle-Free Jet-Injector
6. Frost & Sullivan and International Safety Equipment Association (ISEA) Present a Webinar on the Economy: Personal Protective Equipment Industry - Immune to Global Slowdown?
7. Inteck, Inc. has been Selected to Conduct Two Presentations at the 2009 International MUSE Conference
8. China YCT International (OTCBB: CYIG) Strengthens Corporate Governance With Establishment of Audit Committee and Appointments of Three New Independent Directors
9. New Health and Travel Blog Launches to Raise Awareness of International Travel Issues and Trends
10. International Travelers Can Say Good-Bye to Montezumas Revenge With Launch of Travelan(R) in the U.S. From Alaven Consumer Healthcare
11. Stemedica Expands Globally With International Headquarters In Switzerland
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Minneapolis Hosts National Conference on Tobacco or Health October 24-26 on Heels of Minnesota's Statewide, Smoke-Free Law 2Health News:Cepheid Schedules Teleconference and Webcast for Third Quarter 2007 Results 2Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 2Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 3Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 4Health News:Hundreds to Gather for Rally in Celebration of Right to Breathe Clean Air 2Health News:Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines 2Health News:Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines 3Health News:Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines 4Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 2Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 3Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 4
Other Medicine Technology:Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 2Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 3Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 4Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 5Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 6Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 7Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 8Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 9Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 2Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 3Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 4Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 5